SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001493152-22-023381
Filing Date
2022-08-17
Accepted
2022-08-17 20:19:44
Documents
1
Period of Report
2022-08-15

Document Format Files

Seq Description Document Type Size
1 ownership.html 4  
1 ownership.xml 4 5817
  Complete submission text file 0001493152-22-023381.txt   7369
Mailing Address 15 CUSHING IRVINE CA 92618
Business Address 15 CUSHING IRVINE CA 92618 949-409-7600
Oncocyte Corp (Issuer) CIK: 0001642380 (see all company filings)

IRS No.: 271041563 | State of Incorp.: CA | Fiscal Year End: 1231
SIC: 2835 In Vitro & In Vivo Diagnostic Substances

Mailing Address C/O ONCOCYTE CORPORATION, 15 CUSHING IRVINE CA 92618
Business Address
John Anish M. (Reporting) CIK: 0001933248 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-37648 | Film No.: 221176039